US 11999750
Crystalline forms of (S)-5-benzyl-N-(5-methyl-4-oxo-2,3,4,5-tetrahydropyrido [3,2-B][1,4]oxazepin-3-yl)-4H-1,2,4-triazole-3-carboxamide
granted A61PA61P25/00A61P37/00
Quick answer
US patent 11999750 (Crystalline forms of (S)-5-benzyl-N-(5-methyl-4-oxo-2,3,4,5-tetrahydropyrido [3,2-B][1,4]oxazepin-3-yl)-4H-1,2,4-triazole-3-carboxamide) held by DENALI THERAPEUTICS INC. expires Mon May 30 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- DENALI THERAPEUTICS INC.
- Grant date
- Tue Jun 04 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 30 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 18
- CPC classes
- A61P, A61P25/00, A61P37/00